Jul 22, 2026 01:00AM
Jul 22, 2026 01:00AM
Jul 22, 2026 01:00AM
May 20, 2026 07:15AM
May 16, 2026 08:00AM
Feb 27, 2026 06:20AM
Jan 21, 2026 11:45AM Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
Jan 13, 2026 12:19PM
Nov 7, 2025 08:50AM
Nov 7, 2025 08:42AM
Sep 19, 2025 07:59AM
Jul 24, 2025 01:42PM
Jul 24, 2025 01:41PM
Jun 20, 2025 06:19AM Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors
May 6, 2025 01:30AM
Apr 24, 2025 02:14AM
Sep 23, 2024 07:13AM
Jul 26, 2024 06:46AM
Jun 10, 2024 04:54PM
Jun 7, 2024 01:00AM
May 2, 2024 01:30AM Ipsen appoints Keira Driansky as EVP, President of North America
Apr 24, 2024 01:00AM
Feb 13, 2024 04:08PM
Dec 7, 2023 01:00AM
Nov 13, 2023 07:00AM
Oct 23, 2023 01:00AM
Sep 4, 2023 01:00AM
Sep 1, 2023 01:00AM Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet
Aug 16, 2023 03:32PM
Jul 21, 2023 08:52AM
Jul 21, 2023 07:52AM
Jul 19, 2023 12:42PM
Jun 28, 2023 08:00PM
Jun 14, 2023 04:35PM
Jun 14, 2023 02:21PM Ipsen announces U.S. FDA submission acceptance of its supplemental New Drug Application for Onivyde regimen in first-line metastatic pancreatic ductal adenocarcinoma
Jun 13, 2023 01:10PM
Jun 12, 2023 01:00AM
May 26, 2023 08:20AM
Apr 27, 2023 01:00AM
Apr 24, 2023 02:00AM
Mar 16, 2023 02:02PM
Mar 2, 2023 02:13PM Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
Feb 15, 2023 01:00AM
Feb 13, 2023 05:00PM
Feb 9, 2023 01:00AM
Jan 27, 2023 01:00AM
Jan 20, 2023 10:00AM
Jan 9, 2023 04:52AM
Jan 9, 2023 01:00AM Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases
Dec 23, 2022 05:00PM

1,207,417 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All